bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table 4 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Authors: Capdevila Jaume , Arqués Oriol , Hernández Mora Jose Ramón , Matito Judit , Caratù Ginevra , Mancuso Francesco M. , Landolfi Stefania , Barriuso Jorge , Jimenez-Fonseca Paula , Lopez Lopez Carlos , Garcia-Carbonero Rocio , Hernando Jorge , Matos Ignacio , Paolo Nuciforo , Hernández-Losa Javier , Esteller Manel , Martínez-Cardús Anna , Tabernero Josep , Vivancos Ana , Palmer Héctor G.
Published: April 2023

Supplementary Table 4
Supplementary Figure 2 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Authors: Capdevila Jaume , Arqués Oriol , Hernández Mora Jose Ramón , Matito Judit , Caratù Ginevra , Mancuso Francesco M. , Landolfi Stefania , Barriuso Jorge , Jimenez-Fonseca Paula , Lopez Lopez Carlos , Garcia-Carbonero Rocio , Hernando Jorge , Matos Ignacio , Paolo Nuciforo , Hernández-Losa Javier , Esteller Manel , Martínez-Cardús Anna , Tabernero Josep , Vivancos Ana , Palmer Héctor G.
Published: April 2023

Supplementary Figure 2
Supplementary Data from Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Authors: Seiler Roland , Gibb Ewan A. , Wang Natalie Q. , Oo Htoo Zarni , Lam Hung-Ming , van Kessel Kim E. , Voskuilen Charlotte S. , Winters Brian , Erho Nicholas , Takhar Mandeep M. , Douglas James , Vakar-Lopez Funda , Crabb Simon J. , van Rhijn Bas W.G. , Fransen van de Putte Elisabeth E. , Zwarthoff Ellen C. , Thalmann George N. , Davicioni Elai , Boormans Joost L. , Dall'Era Marc , van der Heijden Michiel S. , Wright Jonathan L. , Black Peter C.
Published: April 2023

Supplementary Figure S7
Supplementary Tables 1-4 and Supplementary Figures S1A and S1B. from Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Authors: Aggarwal Charu , Cohen Roger B. , Morrow Matthew P. , Kraynyak Kimberly A. , Sylvester Albert J. , Knoblock Dawson M. , Bauml Joshua M. , Weinstein Gregory S. , Lin Alexander , Boyer Jean , Sakata Lindsay , Tan Sophie , Anton Aubrey , Dickerson Kelsie , Mangrolia Drishty , Vang Russell , Dallas Michael , Oyola Sandra , Duff Susan , Esser Mark , Kumar Rakesh , Weiner David , Csiki Ildiko , Bagarazzi Mark L.
Published: April 2023

Supplemental Table 2: Number of patients in each cohort with any seroreactivity against the candidate antigens (HPV 16,18 E6 and E7) at (A) any timepoint following vaccination and (B) three months following final vaccination Supplemental Table 3: Flow cytometry output frequencies for HPV16 specific CD8+ T cells before and after treatment with MEDI0457 Supplemental Table 4: Flow cytometry output frequencies for HPV18 specific CD8+ T cells before and after treatment with MEDI0457 Supplementary Figure S1A: Flow Cytometry Gating for assessment of CD3+ CD8+ cells Supplementary Figure S1B: Differential expression of CD38, CD69 and CD137 on CD3+ CD8+ cells before and after activation
Supplementary Table 1 from Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Authors: Aggarwal Charu , Cohen Roger B. , Morrow Matthew P. , Kraynyak Kimberly A. , Sylvester Albert J. , Knoblock Dawson M. , Bauml Joshua M. , Weinstein Gregory S. , Lin Alexander , Boyer Jean , Sakata Lindsay , Tan Sophie , Anton Aubrey , Dickerson Kelsie , Mangrolia Drishty , Vang Russell , Dallas Michael , Oyola Sandra , Duff Susan , Esser Mark , Kumar Rakesh , Weiner David , Csiki Ildiko , Bagarazzi Mark L.
Published: April 2023

Supplementary Table 1: Adverse Events Amongst All Patients Treated on Trial (n=22)
Supplementary Table S2 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Table S2
Supplementary Data from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

supplementary data clean
Supplementary Table 5 from Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
Authors: Rashid Naim U. , Peng Xianlu L. , Jin Chong , Moffitt Richard A. , Volmar Keith E. , Belt Brian A. , Panni Roheena Z. , Nywening Timothy M. , Herrera Silvia G. , Moore Kristin J. , Hennessey Sarah G. , Morrison Ashley B. , Kawalerski Ryan , Nayyar Apoorve , Chang Audrey E. , Schmidt Benjamin , Kim Hong Jin , Linehan David C. , Yeh Jen Jen
Published: April 2023

Table S5
Supplementary Table 3 from Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
Authors: Rashid Naim U. , Peng Xianlu L. , Jin Chong , Moffitt Richard A. , Volmar Keith E. , Belt Brian A. , Panni Roheena Z. , Nywening Timothy M. , Herrera Silvia G. , Moore Kristin J. , Hennessey Sarah G. , Morrison Ashley B. , Kawalerski Ryan , Nayyar Apoorve , Chang Audrey E. , Schmidt Benjamin , Kim Hong Jin , Linehan David C. , Yeh Jen Jen
Published: April 2023

Table S3
Figure S3 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Figure S3
Supplementary Data from Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy
Authors: Sharma Padmanee , Sohn Joohyuk , Shin Sang Joon , Oh Do-Youn , Keam Bhumsuk , Lee Hyo Jin , Gizzi Marco , Kalinka Ewa , de Vos Filip Y.F.L. , Ruscica Dario , Ferro Salvatore , Xiao Feng , Baverel Paul , Chen Cecil Chi-Keung , Asubonteng Kobby , Morsli Nassim , Dirix Luc
Published: April 2023

Supplementary Information
Supplementary Figure Legends from BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
Authors: Poh Weijie , Dilley Robert L. , Moliterno Alison R. , Maciejewski Jaroslaw P. , Pratz Keith W. , McDevitt Michael A. , Herman James G.
Published: April 2023

Figure legends for Supplementary Fig S1, S2
Supplementary Data from BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
Authors: Poh Weijie , Dilley Robert L. , Moliterno Alison R. , Maciejewski Jaroslaw P. , Pratz Keith W. , McDevitt Michael A. , Herman James G.
Published: April 2023

Table S2 shows the BRCA1 qMSP results of samples assayed for HR status
Figure S2 from BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
Authors: Poh Weijie , Dilley Robert L. , Moliterno Alison R. , Maciejewski Jaroslaw P. , Pratz Keith W. , McDevitt Michael A. , Herman James G.
Published: April 2023

Figure S2 shows the BRCA1 qMSP results and HR functional status of the patient samples at multiple time points.
Supplementary Data from A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia
Authors: Ghobrial Irene M. , Vij Ravi , Siegel David , Badros Ashraf , Kaufman Jonathan , Raje Noopur , Jakubowiak Andrzej , Savona Michael R. , Obreja Mihaela , Berdeja Jesus G.
Published: April 2023

Supplementary Methods, Tables and Figures
Supplementary Data #2 from Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma
Authors: Zhu Guo Gord , Nafa Khedoudja , Agaram Narasimhan , Zehir Ahmet , Benayed Ryma , Sadowska Justyna , Borsu Laetitia , Kelly Ciara , Tap William D. , Fabbri Nicola , Athanasian Edward , Boland Patrick J. , Healey John H. , Berger Michael F. , Ladanyi Marc , Hameed Meera
Published: April 2023

CHS clinical data
Supporting Information from Cancer-associated Fibroblast–promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma
Authors: Zhang Hongfang , Hua Yuhui , Jiang Zhenzhen , Yue Jing , Shi Ming , Zhen Xiaoli , Zhang Xiaoyan , Yang Ling , Zhou Rongjing , Wu Shixiu
Published: April 2023

Supporting Information Supplementary Table. S1. The information of 138 ESCC patients used for in situ hybridization assay. Supplementary Table. S2. The targets of kinase inhibitors used in our study. Supplementary Table S3. Genes primers for qRT-PCR analysis
Supplementary Data from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Authors: Wen Patrick Y. , Reardon David A. , Armstrong Terri S. , Phuphanich Surasak , Aiken Robert D. , Landolfi Joseph C. , Curry William T. , Zhu Jay-Jiguang , Glantz Michael , Peereboom David M. , Markert James M. , LaRocca Renato , O'Rourke Donald M. , Fink Karen , Kim Lyndon , Gruber Michael , Lesser Glenn J. , Pan Edward , Kesari Santosh , Muzikansky Alona , Pinilla Clemencia , Santos Radleigh G. , Yu John S.
Published: April 2023

Text
Supplementary Data 2 from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Authors: Wen Patrick Y. , Reardon David A. , Armstrong Terri S. , Phuphanich Surasak , Aiken Robert D. , Landolfi Joseph C. , Curry William T. , Zhu Jay-Jiguang , Glantz Michael , Peereboom David M. , Markert James M. , LaRocca Renato , O'Rourke Donald M. , Fink Karen , Kim Lyndon , Gruber Michael , Lesser Glenn J. , Pan Edward , Kesari Santosh , Muzikansky Alona , Pinilla Clemencia , Santos Radleigh G. , Yu John S.
Published: April 2023

Supplemental Fig 2
Supplementary Data 1 from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Authors: Wen Patrick Y. , Reardon David A. , Armstrong Terri S. , Phuphanich Surasak , Aiken Robert D. , Landolfi Joseph C. , Curry William T. , Zhu Jay-Jiguang , Glantz Michael , Peereboom David M. , Markert James M. , LaRocca Renato , O'Rourke Donald M. , Fink Karen , Kim Lyndon , Gruber Michael , Lesser Glenn J. , Pan Edward , Kesari Santosh , Muzikansky Alona , Pinilla Clemencia , Santos Radleigh G. , Yu John S.
Published: April 2023

Supplemental Fig 1
Supplementary Figures from A Novel Orally Active Inverse Agonist of Estrogen-related Receptor Gamma (ERRγ), DN200434, A Booster of NIS in Anaplastic Thyroid Cancer
Authors: Singh Thoudam Debraj , Song Jaeyoung , Kim Jina , Chin Jungwook , Ji Hyun Dong , Lee Jae-Eon , Lee Sang Bong , Yoon Heeseok , Yu Ji Hoon , Kim Sang Kyoon , Yoon Ghil Suk , Hwang Hayoung , Lee Ho Won , Oh Ji Min , Lee Sang-Woo , Lee Jaetae , Choi Hueng-Sik , Na Soon-Young , Choi Won-Il , Park Young Joo , Song Young Shin , Kim Young A. , Lee In-Kyu , Cho Sung Jin , Jeon Yong Hyun
Published: April 2023

Supplementary Figures
Figure S7 from Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells
Authors: Cheng Yan , Tang Xin-Ying , Li Yi-Xuan , Zhao Dan-Dan , Cao Qiu-Hua , Wu Hong-Xi , Yang Hong-Bao , Hao Kun , Yang Yong
Published: April 2023

SiRNA mediated-NPY knockdown in prostate cancer cells and its impact on prostate cancer cell proliferation and macrophage cytokine expression.
Figure S5 from Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells
Authors: Cheng Yan , Tang Xin-Ying , Li Yi-Xuan , Zhao Dan-Dan , Cao Qiu-Hua , Wu Hong-Xi , Yang Hong-Bao , Hao Kun , Yang Yong
Published: April 2023

BMDM migration and prostate cancer cell proliferation analysis treated with NE.
Table S2 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
Authors: Spriano Filippo , Chung Elaine Yee Lin , Gaudio Eugenio , Tarantelli Chiara , Cascione Luciano , Napoli Sara , Jessen Katti , Carrassa Laura , Priebe Valdemar , Sartori Giulio , Graham Garrett , Selvanathan Saravana P. , Cavalli Andrea , Rinaldi Andrea , Kwee Ivo , Testoni Monica , Genini Davide , Ye B. Hilda , Zucca Emanuele , Stathis Anastasios , Lannutti Brian , Toretsky Jeffrey A. , Bertoni Francesco
Published: April 2023

Anti-tumor activity of YK-4-279 and TK-216 in lymphomas after 72 h of exposure. Genetic features for DLBCL cells (1,2) are also shown.
Figure S4 from Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells
Authors: Cheng Yan , Tang Xin-Ying , Li Yi-Xuan , Zhao Dan-Dan , Cao Qiu-Hua , Wu Hong-Xi , Yang Hong-Bao , Hao Kun , Yang Yong
Published: April 2023

Immune cell analysis in PC-3 tumor bearing Nu/nu mice.
Table S1 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
Authors: Spriano Filippo , Chung Elaine Yee Lin , Gaudio Eugenio , Tarantelli Chiara , Cascione Luciano , Napoli Sara , Jessen Katti , Carrassa Laura , Priebe Valdemar , Sartori Giulio , Graham Garrett , Selvanathan Saravana P. , Cavalli Andrea , Rinaldi Andrea , Kwee Ivo , Testoni Monica , Genini Davide , Ye B. Hilda , Zucca Emanuele , Stathis Anastasios , Lannutti Brian , Toretsky Jeffrey A. , Bertoni Francesco
Published: April 2023

Cell lines, growth medium and source. All media were supplemented with fetal bovine serum (20%), Penicillin-Streptomycin 5% (Sigma) and L-glutamine (1%).
Table S1 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Table S1. Patient data from the RATHER primary ILC cohort
Table S3 from Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218
Authors: Alvarez Secord Angeles , Bell Burdett Kirsten , Owzar Kouros , Tritchler David , Sibley Alexander B. , Liu Yingmiao , Starr Mark D. , Brady J. Chris , Lankes Heather A. , Hurwitz Herbert I. , Mannel Robert S. , Tewari Krishnansu S. , O'Malley David M. , Gray Heidi , Bakkum-Gamez Jamie N. , Fujiwara Keiichi , Boente Matthew , Deng Wei , Burger Robert A. , Birrer Michael J. , Nixon Andrew B.
Published: April 2023

The medians and ranges for all analytes at baseline.
Supplementary Data from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

supplementary data figure legends updated to include wnt11 knockdown data in FigS3 (untracked)
Figures S4 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Figure S4. Induction of FGFR1 following JQ1 treatment in ILC and IDC cell lines.
Figure S6 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Figure S6. BRD3 and BRD4 are associated with disease-specific survival in METABRIC cohort.
Figure S5 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Figure S5: FGFR1 and JQ1 combination in 3D cultures of CAMA1 and IDC cell lines
Figure S3 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Updated FigS3 to include wnt11 knockdown data
Figure S2 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Figure S2. JQ1 in combination with 1ï�­M ABT-199 does not show synergy in ILC cell lines in 2D culture.
Figure S6 from Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection
Authors: Bam Rakesh , Lown Patrick S. , Stern Lawrence A. , Sharma Karina , Wilson Katheryne E. , Bean Gregory R. , Lutz Amelie M. , Paulmurugan Ramasamy , Hackel Benjamin J. , Dahl Jeremy , Abou-Elkacem Lotfi
Published: April 2023

B7-H3 expression on the tumor-associated vasculature of transgenic mouse model.
Figure S1 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer
Authors: Walsh Louise , Haley Kathryn E. , Moran Bruce , Mooney Brian , Tarrant Finbarr , Madden Stephen F. , Di Grande Alessandra , Fan Yue , Das Sudipto , Rueda Oscar M. , Dowling Catríona M. , Varešlija Damir , Chin Suet-Feung , Linn Sabine , Young Leonie S. , Jirström Karin , Crown John P. , Bernards Rene , Caldas Carlos , Gallagher William M. , O'Connor Darran P. , Ní Chonghaile Tríona
Published: April 2023

Figure S1. Characterization of MM134, SUM44, CAMA-1 and OCUB-M ILC cell lines.
Figure S5 from Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection
Authors: Bam Rakesh , Lown Patrick S. , Stern Lawrence A. , Sharma Karina , Wilson Katheryne E. , Bean Gregory R. , Lutz Amelie M. , Paulmurugan Ramasamy , Hackel Benjamin J. , Dahl Jeremy , Abou-Elkacem Lotfi
Published: April 2023

Characterization of MDA-MB-231/f-luc, MS1WT/r-luc, and MS1hB7-H3/r-luc cells.
Supplementary Tables 1-5 and Supplementary Figure Legends 1-3 from Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Authors: Raut Chandrajit P. , Callegaro Dario , Miceli Rosalba , Barretta Francesco , Rutkowski Piotr , Blay Jean-Yves , Lahat Guy , Strauss Dirk C. , Gonzalez Ricardo , Ahuja Nita , Grignani Giovanni , Quagliuolo Vittorio , Stoeckle Eberhard , De Paoli Antonino , Pillarisetty Venu G. , Nessim Carolyn , Swallow Carol J. , Bagaria Sanjay , Canter Robert , Mullen John , Gelderblom Hans J. , Pennacchioli Elisabetta , van Coevorden Frits , Cardona Kenneth , Fiore Marco , Fairweather Mark , Gronchi Alessandro
Published: April 2023

Supplementary Tables and Figure Legends
Supplementary Figure 3 from Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Authors: Raut Chandrajit P. , Callegaro Dario , Miceli Rosalba , Barretta Francesco , Rutkowski Piotr , Blay Jean-Yves , Lahat Guy , Strauss Dirk C. , Gonzalez Ricardo , Ahuja Nita , Grignani Giovanni , Quagliuolo Vittorio , Stoeckle Eberhard , De Paoli Antonino , Pillarisetty Venu G. , Nessim Carolyn , Swallow Carol J. , Bagaria Sanjay , Canter Robert , Mullen John , Gelderblom Hans J. , Pennacchioli Elisabetta , van Coevorden Frits , Cardona Kenneth , Fiore Marco , Fairweather Mark , Gronchi Alessandro
Published: April 2023

Supplementary Figure 3
Table S3 from Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy
Authors: Weinmann Sheila , Leo Michael C. , Francisco Melanie , Jenkins Charisma L. , Barry Todd , Leesman Glen , Linke Steven P. , Whitworth Pat W. , Patel Rakesh , Pellicane James , Wärnberg Fredrik , Bremer Troy
Published: April 2023

10-year total breast event risk for patients treated with radiation therapy and optionally with endocrine therapy compared to those with no endocrine therapy, by DS risk groups
Supplementary Figure 1E from Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Authors: Raut Chandrajit P. , Callegaro Dario , Miceli Rosalba , Barretta Francesco , Rutkowski Piotr , Blay Jean-Yves , Lahat Guy , Strauss Dirk C. , Gonzalez Ricardo , Ahuja Nita , Grignani Giovanni , Quagliuolo Vittorio , Stoeckle Eberhard , De Paoli Antonino , Pillarisetty Venu G. , Nessim Carolyn , Swallow Carol J. , Bagaria Sanjay , Canter Robert , Mullen John , Gelderblom Hans J. , Pennacchioli Elisabetta , van Coevorden Frits , Cardona Kenneth , Fiore Marco , Fairweather Mark , Gronchi Alessandro
Published: April 2023

Supplementary Figure 1E
Table S2 from Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy
Authors: Weinmann Sheila , Leo Michael C. , Francisco Melanie , Jenkins Charisma L. , Barry Todd , Leesman Glen , Linke Steven P. , Whitworth Pat W. , Patel Rakesh , Pellicane James , Wärnberg Fredrik , Bremer Troy
Published: April 2023

10-year risks by DS risk group and radiation therapy in evaluable patients with negative margin status
Supplementary Figure 1D from Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Authors: Raut Chandrajit P. , Callegaro Dario , Miceli Rosalba , Barretta Francesco , Rutkowski Piotr , Blay Jean-Yves , Lahat Guy , Strauss Dirk C. , Gonzalez Ricardo , Ahuja Nita , Grignani Giovanni , Quagliuolo Vittorio , Stoeckle Eberhard , De Paoli Antonino , Pillarisetty Venu G. , Nessim Carolyn , Swallow Carol J. , Bagaria Sanjay , Canter Robert , Mullen John , Gelderblom Hans J. , Pennacchioli Elisabetta , van Coevorden Frits , Cardona Kenneth , Fiore Marco , Fairweather Mark , Gronchi Alessandro
Published: April 2023

Supplementary Figure 1D
Supplementary Figure 1C from Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Authors: Raut Chandrajit P. , Callegaro Dario , Miceli Rosalba , Barretta Francesco , Rutkowski Piotr , Blay Jean-Yves , Lahat Guy , Strauss Dirk C. , Gonzalez Ricardo , Ahuja Nita , Grignani Giovanni , Quagliuolo Vittorio , Stoeckle Eberhard , De Paoli Antonino , Pillarisetty Venu G. , Nessim Carolyn , Swallow Carol J. , Bagaria Sanjay , Canter Robert , Mullen John , Gelderblom Hans J. , Pennacchioli Elisabetta , van Coevorden Frits , Cardona Kenneth , Fiore Marco , Fairweather Mark , Gronchi Alessandro
Published: April 2023

Supplementary Figure 1C
Supplementary Figure 1B from Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Authors: Raut Chandrajit P. , Callegaro Dario , Miceli Rosalba , Barretta Francesco , Rutkowski Piotr , Blay Jean-Yves , Lahat Guy , Strauss Dirk C. , Gonzalez Ricardo , Ahuja Nita , Grignani Giovanni , Quagliuolo Vittorio , Stoeckle Eberhard , De Paoli Antonino , Pillarisetty Venu G. , Nessim Carolyn , Swallow Carol J. , Bagaria Sanjay , Canter Robert , Mullen John , Gelderblom Hans J. , Pennacchioli Elisabetta , van Coevorden Frits , Cardona Kenneth , Fiore Marco , Fairweather Mark , Gronchi Alessandro
Published: April 2023

Supplementary Figure 1B
Supplementary Figure S1 from The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors
Authors: Kim Kyung Hwan , Cho Jinhyun , Ku Bo Mi , Koh Jiae , Sun Jong-Mu , Lee Se-Hoon , Ahn Jin Seok , Cheon Jaekyung , Min Young Joo , Park Su-Hyung , Park Keunchil , Ahn Myung-Ju , Shin Eui-Cheol
Published: April 2023

Supplementary Figure S1
Supplementary Materials from Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers
Authors: Cho Sung-Yup , Chae Jeesoo , Na Deukchae , Kang Wonyoung , Lee Ahra , Min Seoyeon , Kang Jinjoo , Choi Boram , Lee Jieun , Sung Chang Ohk , Chuang Jeffrey H. , Lee Charles , Lee Won-Suk , Park Hansoo , Kim Jong-Il
Published: April 2023

Supplementary Materials and Methods, Supplementary Figures S1-S10 and Supplementary Tables S1-S6
Supplementary Data from Imaging Phenotypes of Breast Cancer Heterogeneity in Preoperative Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) Scans Predict 10-Year Recurrence
Authors: Chitalia Rhea D. , Rowland Jennifer , McDonald Elizabeth S. , Pantalone Lauren , Cohen Eric A. , Gastounioti Aimilia , Feldman Michael , Schnall Mitchell , Conant Emily , Kontos Despina
Published: April 2023

Supplementary data includes appendix of extracted Radiomic features. Figure S1 shows a summary of patient characteristics. Figure S2 shows the radiomic analysis workflow. Figure S3 shows representative cases from heterogeneity phenotypes. Figure S4 shows independent validation of intrinsic imaging phenotypes of tumor heterogeneity.
Figure S4 from Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes
Authors: Shin Myeong-Kyun , Payne Susan , Bilger Andrea , Matkowskyj Kristina A. , Carchman Evie , Meyer Dominique S. , Bentires-Alj Mohamed , Deming Dustin A. , Lambert Paul F.
Published: April 2023

Figure S4. Examination of the change of the change in differentiation /maturation by treatment of TAK-228
Figure S2 from Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes
Authors: Shin Myeong-Kyun , Payne Susan , Bilger Andrea , Matkowskyj Kristina A. , Carchman Evie , Meyer Dominique S. , Bentires-Alj Mohamed , Deming Dustin A. , Lambert Paul F.
Published: April 2023

Figure S2. Evaluation of the location of anal cancers, and expression of biomarkers, MCM7 and p-S6, in anal cancers from DMBA-treated mice.
Figure S1 from Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes
Authors: Shin Myeong-Kyun , Payne Susan , Bilger Andrea , Matkowskyj Kristina A. , Carchman Evie , Meyer Dominique S. , Bentires-Alj Mohamed , Deming Dustin A. , Lambert Paul F.
Published: April 2023

Figure S1. Classification of anal tumors by location
Figure S2 from Postablation Modulation after Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation
Authors: Savage Talicia , Pandey Sanjay , Guha Chandan
Published: April 2023

Local PAM-RT treatment in 4T1 tumor bearing mice.
Table S7 from Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer
Authors: Goldstein Jennifer B. , Zhao Li , Wang Xuemei , Ghelman Yael , Overman Michael J. , Javle Milind M. , Shroff Rachna T. , Varadhachary Gauri R. , Wolff Robert A. , McAllister Florencia , Futreal Andrew , Fogelman David R.
Published: April 2023

Multivariable logistic regression model for deleterious mutation among 133 sequenced subjects (n = 26 with deleterious mutation).
Supplementary Data from Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy
Authors: Liu Yuting , Zugazagoitia Jon , Ahmed Fahad Shabbir , Henick Brian S. , Gettinger Scott N. , Herbst Roy S. , Schalper Kurt A. , Rimm David L.
Published: April 2023

Supp figures and tables
Supplementary Methods and Results from High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy
Authors: Eranki Avinash , Srinivasan Priya , Ries Mario , Kim AeRang , Lazarski Christopher A. , Rossi Christopher T. , Khokhlova Tatiana D. , Wilson Emmanuel , Knoblach Susan M. , Sharma Karun V. , Wood Bradford J. , Moonen Chrit , Sandler Anthony D. , Kim Peter C.W.
Published: April 2023

This file includes supplementary methods and results.
Figure S7 from High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy
Authors: Eranki Avinash , Srinivasan Priya , Ries Mario , Kim AeRang , Lazarski Christopher A. , Rossi Christopher T. , Khokhlova Tatiana D. , Wilson Emmanuel , Knoblach Susan M. , Sharma Karun V. , Wood Bradford J. , Moonen Chrit , Sandler Anthony D. , Kim Peter C.W.
Published: April 2023

Figure S7. Immune memory effects in mice treated with HIFU+ Î±CTLA-4 + Î±PD-L1
Figure S5 from High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy
Authors: Eranki Avinash , Srinivasan Priya , Ries Mario , Kim AeRang , Lazarski Christopher A. , Rossi Christopher T. , Khokhlova Tatiana D. , Wilson Emmanuel , Knoblach Susan M. , Sharma Karun V. , Wood Bradford J. , Moonen Chrit , Sandler Anthony D. , Kim Peter C.W.
Published: April 2023

Figure S5. Tumor growth curves of left and right limbs of mice with bilateral tumors.
Supplementary Figure S1 from Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma
Authors: Mitani Yoshitsugu , Lin Sue-Hwa , Pytynia Kristen B. , Ferrarotto Renata , El-Naggar Adel K.
Published: April 2023

Loss of GR expression and patients survival.
Figure S3 from High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy
Authors: Eranki Avinash , Srinivasan Priya , Ries Mario , Kim AeRang , Lazarski Christopher A. , Rossi Christopher T. , Khokhlova Tatiana D. , Wilson Emmanuel , Knoblach Susan M. , Sharma Karun V. , Wood Bradford J. , Moonen Chrit , Sandler Anthony D. , Kim Peter C.W.
Published: April 2023

Figure S3. Circulating cellular profile in contralateral lymph nodes after treating mice with HIFU only.
Table S1 from Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Authors: Binzer-Panchal Amrei , Hardell Elin , Viklund Björn , Ghaderi Mehran , Bosse Tjalling , Nucci Marisa R. , Lee Cheng-Han , Hollfelder Nina , Corcoran Pádraic , Gonzalez-Molina Jordi , Moyano-Galceran Lidia , Bell Debra A. , Schoolmeester John K. , Måsbäck Anna , Kristensen Gunnar B. , Davidson Ben , Lehti Kaisa , Isaksson Anders , Carlson Joseph W.
Published: April 2023

Table S1
Figure S1 from Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Authors: Binzer-Panchal Amrei , Hardell Elin , Viklund Björn , Ghaderi Mehran , Bosse Tjalling , Nucci Marisa R. , Lee Cheng-Han , Hollfelder Nina , Corcoran Pádraic , Gonzalez-Molina Jordi , Moyano-Galceran Lidia , Bell Debra A. , Schoolmeester John K. , Måsbäck Anna , Kristensen Gunnar B. , Davidson Ben , Lehti Kaisa , Isaksson Anders , Carlson Joseph W.
Published: April 2023

Supplemental Figure 1
Supplementary Data from EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency
Authors: Fu Wenyan , Lei Changhai , Yu Yue , Liu Shuowu , Li Tian , Lin Fangxing , Fan Xiaoyan , Shen Yafeng , Ding Min , Tang Ying , Ye Xuting , Yang Yongji , Hu Shi
Published: April 2023

Supplementary methods, Supplementary figures and tables
Supplemental Methods, Figures and Tables from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
Authors: Groot Vincent P. , Mosier Stacy , Javed Ammar A. , Teinor Jonathan A. , Gemenetzis Georgios , Ding Ding , Haley Lisa M. , Yu Jun , Burkhart Richard A. , Hasanain Alina , Debeljak Marija , Kamiyama Hirohiko , Narang Amol , Laheru Daniel A. , Zheng Lei , Lin Ming-Tseh , Gocke Christopher D. , Fishman Elliot K. , Hruban Ralph H. , Goggins Michael G. , Molenaar I. Quintus , Cameron John L. , Weiss Matthew J. , Velculescu Victor E. , He Jin , Wolfgang Christopher L. , Eshleman James R.
Published: April 2023

Supplemental Methods, Figures and Tables
Table S5 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia
Authors: Tarlock Katherine , Alonzo Todd A. , Wang Yi-Cheng , Gerbing Robert B. , Ries Rhonda , Loken Michael R. , Pardo Laura , Hylkema Tiffany , Joaquin Jason , Sarukkai Leela , Raimondi Susana C. , Hirsch Betsy , Sung Lillian , Aplenc Richard , Bernstein Irwin , Gamis Alan S. , Meshinchi Soheil , Pollard Jessica A.
Published: April 2023

Supplementary Table 5. Outcome for KIT E8+ mutation positive patients according to treatment arm (No GO vs. GO)
Table S5 from Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Authors: Bernard Vincent , Semaan Alexander , Huang Jonathan , San Lucas F. Anthony , Mulu Feven C. , Stephens Bret M. , Guerrero Paola A. , Huang Yanqing , Zhao Jun , Kamyabi Nabiollah , Sen Subrata , Scheet Paul A. , Taniguchi Cullen M. , Kim Michael P. , Tzeng Ching-Wei , Katz Matthew H. , Singhi Aatur D. , Maitra Anirban , Alvarez Hector A.
Published: April 2023

Pathway analysis among lesions
Table S4 from Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Authors: Bernard Vincent , Semaan Alexander , Huang Jonathan , San Lucas F. Anthony , Mulu Feven C. , Stephens Bret M. , Guerrero Paola A. , Huang Yanqing , Zhao Jun , Kamyabi Nabiollah , Sen Subrata , Scheet Paul A. , Taniguchi Cullen M. , Kim Michael P. , Tzeng Ching-Wei , Katz Matthew H. , Singhi Aatur D. , Maitra Anirban , Alvarez Hector A.
Published: April 2023

Pancreatic cancer core signaling pathways across lesion types
Figure S3 from Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia
Authors: Tarlock Katherine , Alonzo Todd A. , Wang Yi-Cheng , Gerbing Robert B. , Ries Rhonda , Loken Michael R. , Pardo Laura , Hylkema Tiffany , Joaquin Jason , Sarukkai Leela , Raimondi Susana C. , Hirsch Betsy , Sung Lillian , Aplenc Richard , Bernstein Irwin , Gamis Alan S. , Meshinchi Soheil , Pollard Jessica A.
Published: April 2023

Supplementary Figure 3. CD117 expression as measured by MFI of Ba/F3 cell lines transduced with KIT-WT as well E17, E8, and E11 KIT mutations.
Figure S5 from Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Authors: Bernard Vincent , Semaan Alexander , Huang Jonathan , San Lucas F. Anthony , Mulu Feven C. , Stephens Bret M. , Guerrero Paola A. , Huang Yanqing , Zhao Jun , Kamyabi Nabiollah , Sen Subrata , Scheet Paul A. , Taniguchi Cullen M. , Kim Michael P. , Tzeng Ching-Wei , Katz Matthew H. , Singhi Aatur D. , Maitra Anirban , Alvarez Hector A.
Published: April 2023

Tapestation traces following (A) cDNA amplification of single cell and (B) library construction demonstrating sufficient quality and yield of material. Vertical lines demonstrate regions utilized to calculate cDNA and library yield through area under the curve.
Figure S1 from Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Authors: Bernard Vincent , Semaan Alexander , Huang Jonathan , San Lucas F. Anthony , Mulu Feven C. , Stephens Bret M. , Guerrero Paola A. , Huang Yanqing , Zhao Jun , Kamyabi Nabiollah , Sen Subrata , Scheet Paul A. , Taniguchi Cullen M. , Kim Michael P. , Tzeng Ching-Wei , Katz Matthew H. , Singhi Aatur D. , Maitra Anirban , Alvarez Hector A.
Published: April 2023

(A) Correlation of gene expression levels in a pancreatic cancer cell line between single cells, bulk cells, and across independent replicates. (Single cell vs Bulk, R2: 0.915 and R2:0.9 for genesBoth {greater than or equal to}1 (N=14,922) and {greater than or equal to}10 (N=11,574) respectively. Independent Cell Replicates, R2: 0.937 and R2: 0.955 for genesBoth {greater than or equal to}1 (N=13,791) and {greater than or equal to}10 (N=10,609) respectively). (B) Scatter plots of number of UMIs against number of genes expressed and percentage of mitochondrial genes expressed per single cell across independent tissue samples from pancreatic lesions (different colors). (C) Violin plots of number of genes, UMIs, and percentage of mitochondrial genes expressed per single cell from tissue samples profiled in this study. (D) Principal components (PC) elbow plot to determine the elbow between the standard deviation of the PC and the number of PCs (11).
Figure S2 from lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP
Authors: Li Nan , Yang Guohua , Luo Liyun , Ling Li , Wang Xiaorong , Shi Lejuan , Lan Junsong , Jia Xiaoting , Zhang Qiong , Long Ze , Liu Jinbao , Hu Weimin , He Zhimin , Liu Haiying , Liu Wanqing , Zheng Guopei
Published: April 2023

Figure S2, related to Figure 2. THAP9-AS1 promotes PDAC growth.
Figure S1 from lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP
Authors: Li Nan , Yang Guohua , Luo Liyun , Ling Li , Wang Xiaorong , Shi Lejuan , Lan Junsong , Jia Xiaoting , Zhang Qiong , Long Ze , Liu Jinbao , Hu Weimin , He Zhimin , Liu Haiying , Liu Wanqing , Zheng Guopei
Published: April 2023

Figure S1, related to Figure 1. THAP9-AS1 as a lncRNA is upregulated in PDAC.
Table S4 from Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy
Authors: Hai Josephine , Zhang Hua , Zhou Jin , Wu Zhong , Chen Ting , Papadopoulos Eleni , Dowling Catríona M. , Pyon Val , Pan Yuanwang , Liu Jie Bin , Bronson Roderick T. , Silver Heather , Lizotte Patrick H. , Deng Jiehui , Campbell Joshua D. , Sholl Lynette M. , Ng Christine , Tsao Ming-Sound , Thakurdin Cassandra , Bass Adam J. , Wong Kwok-Kin
Published: April 2023

qRT-PCR primer sequences
Supplementary Data from Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair–Deficient Colon Cancers: Implications for Prognosis
Authors: Yoon Harry H. , Shi Qian , Heying Erica N. , Muranyi Andrea , Bredno Joerg , Ough Faith , Djalilvand Azita , Clements June , Bowermaster Rebecca , Liu Wen-Wei , Barnes Michael , Alberts Steven R. , Shanmugam Kandavel , Sinicrope Frank A.
Published: April 2023

Figure S3 Backward selection to identify T-cell subtype(s) independently associated with overall survival in mismatch-repair deficient stage III colon cancers
Supplementary Data from Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair–Deficient Colon Cancers: Implications for Prognosis
Authors: Yoon Harry H. , Shi Qian , Heying Erica N. , Muranyi Andrea , Bredno Joerg , Ough Faith , Djalilvand Azita , Clements June , Bowermaster Rebecca , Liu Wen-Wei , Barnes Michael , Alberts Steven R. , Shanmugam Kandavel , Sinicrope Frank A.
Published: April 2023

Suppl Figure Legend
Supplementary Data from A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
Authors: Ghobrial Irene M. , Liu Chia-Jen , Redd Robert A. , Perez Raymond P. , Baz Rachid , Zavidij Oksana , Sklavenitis-Pistofidis Romanos , Richardson Paul G. , Anderson Kenneth C. , Laubach Jacob , Henrick Patrick , Savell Alexandra , Reyes Kaitlen , Hornburg Kalvis , Chuma Stacey , Sabbatini Peter , Robbins Michael D. , Becker Pamela S.
Published: April 2023

This file contains the legends for the supplementary figures.
Supplementary figure legends from Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Authors: Flores-Morales Amilcar , Bergmann Tobias B. , Lavallee Charlotte , Batth Tanveer S. , Lin Dong , Lerdrup Mads , Friis Stine , Bartels Anette , Kristensen Gitte , Krzyzanowska Agnieszka , Xue Hui , Fazli Ladan , Hansen Klaus H. , Røder Martin A. , Brasso Klaus , Moreira José M. , Bjartell Anders , Wang Yuzhuo , Olsen Jesper V. , Collins Colin C. , Iglesias-Gato Diego
Published: April 2023

Supplementary figure legends
Supplementary Table 1 from Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Authors: Blakeley Jaishri O. , Grossman Stuart A. , Chi Andrew S. , Mikkelsen Tom , Rosenfeld Myrna R. , Ahluwalia Manmeet S. , Nabors L. Burt , Eichler April , Ribas Ignacio Garcia , Desideri Serena , Ye Xiaobu
Published: April 2023

Supplementary Table 1 from Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Supplemental Legend from Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Authors: Keung Emily Z. , Burgess Melissa , Salazar Ruth , Parra Edwin R. , Rodrigues-Canales Jaime , Bolejack Vanessa , Van Tine Brian A. , Schuetze Scott M. , Attia Steven , Riedel Richard F. , Hu James , Okuno Scott H. , Priebat Dennis A. , Movva Sujana , Davis Lara E. , Reed Damon R. , Reuben Alexandre , Roland Christina L. , Reinke Denise , Lazar Alexander J. , Wang Wei-Lien , Wargo Jennifer A. , Tawbi Hussein A.
Published: April 2023

Supplemental Legend
Figure S3 from Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator–activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue
Authors: Wilson Hannah E. , Rhodes Kacey K. , Rodriguez Daniel , Chahal Ikttesh , Stanton David A. , Bohlen Joseph , Davis Mary , Infante Aniello M. , Hazard-Jenkins Hannah , Klinke David J. , Pugacheva Elena N. , Pistilli Emidio E.
Published: April 2023

Figure S3 shows muscle fatigue and twitch properties of EDL muscles form E0771 tumor bearing mice.
Supplementary Figures from Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models
Authors: Zhang Mo , Kobayashi Naoko , Zettlitz Kirstin A. , Kono Evelyn A. , Yamashiro Joyce M. , Tsai Wen-Ting K. , Jiang Ziyue K. , Tran Chau P. , Wang Chung , Guan Johnny , Wu Anna M. , Reiter Robert E.
Published: April 2023

Supplementary Figure S1, S2, S3, S4, S5, S6, S7
Figure S2 from Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator–activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue
Authors: Wilson Hannah E. , Rhodes Kacey K. , Rodriguez Daniel , Chahal Ikttesh , Stanton David A. , Bohlen Joseph , Davis Mary , Infante Aniello M. , Hazard-Jenkins Hannah , Klinke David J. , Pugacheva Elena N. , Pistilli Emidio E.
Published: April 2023

Figure S2 shows linear regression analysis of body weight loss versus Pparg gene expression in E0771 tumor bearing mice.
Supplementary Tables from Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability–High Colorectal Cancers
Authors: Sato Kazuhito , Kawazu Masahito , Yamamoto Yoko , Ueno Toshihide , Kojima Shinya , Nagae Genta , Abe Hiroyuki , Soda Manabu , Oga Takafumi , Kohsaka Shinji , Sai Eirin , Yamashita Yoshihiro , Iinuma Hisae , Fukayama Masashi , Aburatani Hiroyuki , Watanabe Toshiaki , Mano Hiroyuki
Published: April 2023

Supplementary Tables S1-S12: Supplementary Table S1: Primer sequences used in this study. Supplementary Table S2: Clinical information of tumours analysed in the present study. Supplementary Table S3: Patients' characteristics. Supplementary Table S4: Likely causal mutations in mismatch repair genes detected in this study. Supplementary Table S5: List of Tier 2 mutations. Supplementary Table S6: Significantly mutated genes identified with MutSigCV. Supplementary Table S7: Genes differentially altered between Lynch syndrome-associated/Lynch-like tumours and MLH1 promoter-methylated tumours. Supplementary Table S8: Recurrent copy number alterations detected with allele-specific copy number analysis. Supplementary Table S9: Pathways detected from top 209 Tier 2 genes with The Database for Annotation, Visualization and Integrated Discovery. Supplementary Table S10: Pathways detected from significantly mutated genes with The Database for Annotation, Visualization and Integrated Discovery. Supplementary Table S11: Detected oncogenic alterations and associated mutations with uncertain significance. Supplementary Table S12: Complementary DNA sequences of fusion points confirmed by reverse-transcription polymerase chain reaction followed by Sanger sequencing.